TheHEALTH May/June 2024 | Page 3

May-June . 2024 | The HEALTH

Contents

03

The HEALTH says ...

Transparency is crucial

P20 The shoulder snowstorm Let ’ s dive into the world of calcific tendinitis of the shoulder , a condition that can cause significant pain and discomfort
P21 OFS taken to task for delays Long waits erode the trust and confidence of financial services consumers
P22 Cyberbullying : The mental health impact and strategies Cyberbullying can have far-reaching and significant effects on mental health
P23 E-invoicing in the healthcare industry Its implementation comes with its own set of complexities and considerations compared to e-invoicing in typical businesses
P21
P25
P24 We can change our brains ! Scientists now believe the structure of the brain can change through a process called neuroplasticity
P25 Follow your nose , but heed your gut A hypothesis study has proposed that environmental toxicants are the cause of Parkinson ’ s disease
P26 A culinary crusade against inflammation Turmeric , palm oil , garlic and honey – these unassuming kitchen companions – emerge as valiant warriors against the pervasive threat of inflammation
P27 Blue tooth or the tooth fairy ! A lack of oral care can lead to overall health problems such as heart disease , stroke and diabetes
THE Ministry of Health ( MoH ) has promised to disclose details relating to those affected by the side effects of the Covid-19 vaccines . This commitment made in early May by Health Minister Datuk Seri Dr Dzulkefly Ahmad should be lauded as it is crucial for building public trust .
Dr Dzulkefly has assured that the Ministry maintains comprehensive records of all Covid-19 vaccinations administered in Malaysia , including data on Adverse Events Following Immunisation ( AEFI ) cases and fatalities . This data will be disclosed to the public in due course .
This proactive approach is critical , especially considering recent concerns linking the AstraZeneca ( AZ ) vaccine to Thrombosis with Thrombocytopenia Syndrome ( TTS ). The AZ vaccine , initially known as Covishield and later rebranded as Vaxzevria , was extensively used to fight Covid-19 globally .
Countries like Australia have stopped using it as they transitioned to more updated vaccines . Although there haven ’ t been any TTS cases reported in Malaysia , the Ministry has sought clarification from its manufacturer AstraZeneca , underlining its commitment to transparency and public safety .
There have also been cases of those affected by the Pfizer vaccine . There were reports that these vaccines resulted in an increased risk of myocarditis and pericarditis .
The MoH ’ s decision to disclose AEFI data aligns with the Ministry ’ s broader responsibility to the people . This transparency is a matter of public health policy and a fundamental trust-building measure . It reassures the public that the government is vigilant and accountable , especially when handling sensitive health issues .
On June 6 , 2023 , then Health Minister Dr Zaliha Mustafa revealed that over RM2.5 million had been paid in compensation to 150 individuals who suffered serious side effects from Covid-19 vaccines .
Out of 318 applications for aid , 150 were approved . Most reports of vaccine side effects were minor , with only a few serious cases .
The MoH ’ s commitment to transparency , accountability , and financial support for those adversely affected by the Covid-19 vaccines represents a balanced approach to public health management .
It acknowledges the risks inherent in any mass vaccination programme while reinforcing that such risks are taken seriously and managed responsibly . The public ’ s right to information , especially health and safety matters , cannot be overstated .
This transparency will be crucial as the country continues to navigate the complexities of the Covid-19 pandemic and future health challenges .